ContraFect
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ContraFect and other ETFs, options, and stocks.About CFRX
ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides.
CEORoger J. Pomerantz
CEORoger J. Pomerantz
Employees38
Employees38
HeadquartersYonkers, New York
HeadquartersYonkers, New York
Founded2008
Founded2008
Employees38
Employees38
CFRX Key Statistics
Market cap3.07M
Market cap3.07M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume34.96M
Average volume34.96M
High today$0.075
High today$0.075
Low today$0.0634
Low today$0.0634
Open price$0.0734
Open price$0.0734
Volume42.41M
Volume42.41M
52 Week high$4.54
52 Week high$4.54
52 Week low$0.0634
52 Week low$0.0634
CFRX Earnings
-$0.51
-$0.34
-$0.17
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Mar 23, Pre-Market
ActualExpected Mar 23, Pre-Market